Illumina Named One of Fast Company's Most Innovative Companies for 2022
Illumina honored for developing several innovative technologies, including COVID-19 sequencing tests to track the spread of variants even at smaller labs
Mar 9, 2022 10:00 AM ET
Campaign:
Access
Originally published on LinkedIn
We are honored to have been named one of Fast Company’s Most Innovative Companies for 2022.
A few of our innovative technologies and advancements in 2021 included:
- Introducing the COVIDSeq Assay, which enabled pathogen surveillance in developing countries
- Reaching more than 1 billion covered lives globally for genomic testing
- Launching Illumina Connected Analytics (ICA) to increase the security and privacy of our customers’ data
- Partnering with the Africa CDC and the Bill & Melinda Gates Foundation to help establish an Africa Pathogen Genomics Initiative (APGI)
As an engine of genomics innovation, we understand that the faster we can innovate, the more lives we can impact.
Thank you to our employees, and to the clinicians and researchers we serve, whose passion for the power of genomics made this honor possible.
Learn more about Fast Company's 10 Most Innovative health companies of 2022 here
